ELAVL1 and prostate carcinoma: Consistent with our results, ellagic acid (EA) remarkably enhanced ROS levels, down-regulated HuR, and diminished intracellular levels of β-catenin, thus activating apoptosis via upregulation of caspase-3 and p21 in the human prostate cancer LNCaP cells [39].